188 related articles for article (PubMed ID: 12415591)
1. Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.
Chang ER; Abrahamowicz M; Ferland D; Fortin PR
J Rheumatol; 2002 Nov; 29(11):2350-8. PubMed ID: 12415591
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
3. Do lupus disease activity measures detect clinically important change?
Fortin PR; Abrahamowicz M; Clarke AE; Neville C; Du Berger R; Fraenkel L; Liang MH
J Rheumatol; 2000 Jun; 27(6):1421-8. PubMed ID: 10852264
[TBL] [Abstract][Full Text] [Related]
4. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
[TBL] [Abstract][Full Text] [Related]
6. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians.
Chang E; Abrahamowicz M; Ferland D; Fortin PR;
J Clin Epidemiol; 2002 May; 55(5):488-97. PubMed ID: 12007552
[TBL] [Abstract][Full Text] [Related]
8. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
Brunner HI; Feldman BM; Bombardier C; Silverman ED
Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
[TBL] [Abstract][Full Text] [Related]
10. Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory tests.
Fortin PR; Abrahamowicz M; Danoff D
J Rheumatol; 1995 Nov; 22(11):2078-83. PubMed ID: 8596148
[TBL] [Abstract][Full Text] [Related]
11. Accurately describing changes in disease activity in Systemic Lupus Erythematosus.
Gladman DD; Urowitz MB; Kagal A; Hallett D
J Rheumatol; 2000 Feb; 27(2):377-9. PubMed ID: 10685800
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual.
Bertoli AM; Vilá LM; Apte M; Fessler BJ; Bastian HM; Reveille JD; Alarcón GS;
Rheumatology (Oxford); 2007 Sep; 46(9):1471-6. PubMed ID: 17650522
[TBL] [Abstract][Full Text] [Related]
14. Determinants of discordance between patients and physicians in their assessment of lupus disease activity.
Yen JC; Abrahamowicz M; Dobkin PL; Clarke AE; Battista RN; Fortin PR
J Rheumatol; 2003 Sep; 30(9):1967-76. PubMed ID: 12966600
[TBL] [Abstract][Full Text] [Related]
15. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
16. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
17. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
[TBL] [Abstract][Full Text] [Related]
18. The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials.
Abrahamowicz M; Fortin PR; du Berger R; Nayak V; Neville C; Liang MH
J Rheumatol; 1998 Feb; 25(2):277-84. PubMed ID: 9489819
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus disease activity index 2000.
Gladman DD; Ibañez D; Urowitz MB
J Rheumatol; 2002 Feb; 29(2):288-91. PubMed ID: 11838846
[TBL] [Abstract][Full Text] [Related]
20. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
Brunner HI; Silverman ED; Bombardier C; Feldman BM
Arthritis Rheum; 2003 Jun; 49(3):335-41. PubMed ID: 12794788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
